Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
James Caruso
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
phospholipid drug conjugates
|
| gptkbp:focusesOn |
oncology
|
| gptkbp:foundedYear |
2002
|
| gptkbp:headquartersLocation |
gptkb:Florham_Park,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cellectar Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
CLR 131
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
CLRB
|
| gptkbp:website |
https://www.cellectar.com/
|
| gptkbp:bfsParent |
gptkb:David_Scheinberg
|
| gptkbp:bfsLayer |
8
|